Focus On Business: Neil Goldsmith on Biotechnology

WEKU | By Bryan Bartlett

Published March 21, 2016 at 9:11 AM EDT

What does a grapefruit have in common with a deer tick? Tom Martin found out in talking with Neil Goldsmith, co-founder of Evolva, a Swiss-based biotechnology firm with a significant relationship with Lexington and the University of Kentucky.

7FOB0328.mp3

Tom Martin talks company policy with Neil Goldsmith, CEO of biotech company Evolva.

Related Content

NPR News

Where patients live matters for access to gene therapy

Sydney Lupkin

Gene therapies have the potential to cure some diseases, but they are extraordinarily expensive. Location can also be a big hurdle for patients seeking this specialized care.
NPR News

DOJ hides Trump-related Epstein files. And, what to know for the State of the Union

Brittney Melton

An NPR investigation found that the DOJ withheld some Epstein files related to abuse allegations against Trump. And, what you need to know ahead of the president's State of the Union address tonight.
Trump set to deliver State of the Union address amid economic and diplomatic tensions

Franco Ordoñez, Steve Inskeep

President Trump is set to deliver his first State of the Union address of his second term, as he faces a host of key issues from tariffs to Iran.
Voters share their thoughts on the state of the union ahead of Trump's address

Hosts

Ahead of the State of the Union address, voters describe how they view the economy, immigration and the country's direction.
GOP strategist on what he thinks Trump should focus on in State of the Union address

Leila Fadel

NPR's Leila Fadel speaks with GOP analyst and speechwriter Mike Ricci about Tuesday night's State of the Union address, and how the norms surrounding the speech have changed.